Exploring the mechanism of kaji-ichigoside F1 on bacterial pneumonia based on the network pharmacology and transcriptome
Yang, J.; Yang, X.; Wu, L.; Min, C.
Show abstract
ObjectiveTo explore the anti-inflammatory mechanism of kaji-ichigoside F1 against bacterial pneumonia based on transcriptomics and network pharmacology. MethodNetwork pharmacological was used to analyse the potential target genes of kaji-ichigoside F1 action on bacterial pneumonia; molecular docking was used to analyse the docking binding energy of kaji-ichigoside F1 with key target genes; RAW264.7 macrophages were treated with klebsiella pneumoniae fluid and given kaji-ichigoside F1 intervention, the expression of inflammatory factors IL-1{beta}, IL-6, TNF- and IL-10 were dectected by qRT-PCR; transcriptomic analysis was performed to obtain differentially expressed genes, and relevant signaling pathways. ResultNetwork pharmacological analysis showed that the five the key target genes for kaji-ichigoside F1-bacterial pneumonia interaction were were TLR4, NFKB1, STAT3, IL1B, and JUN; molecular docking results of kaji-ichigoside F1 with key target genes showed the docking binding energy ranging from -5.9 to -8.4 kcal/mol; kaji-ichigoside F1 can reduce the klebsiella pneumoniae induced inflammatory response of macrophages, manifested with reducing the mRNA expression of pro-inflammatory factors IL-1{beta}, IL-6 and TNF-, and increase the mRNA expression of anti-inflammatory factor IL-10; transcriptomics analysis showed that the signaling pathways involved were mainly the TLR signaling pathway and NFKB signaling pathway. ConclusionThis study showed that kaji-ichigoside F1 alleviates bacterial pneumonia by targeting TLR and NFKB signaling pathways, rebalancing macrophage polarization with suppressing pro-inflammatory cytokines and increasing anti-inflammatory cytokines, highlighting kaji-ichigoside F1 as a novel agent for combating bacterial infections. Graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=144 SRC="FIGDIR/small/649383v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@7c96eorg.highwire.dtl.DTLVardef@13977a6org.highwire.dtl.DTLVardef@1de6214org.highwire.dtl.DTLVardef@f91c50_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Umbelliprenin isolated from Ferula sinkiangensis inhibits tumor growth and migration through the disturbance of Wnt signaling pathway in gastric cancer 97%
- Protective Effect of Cannabinoid Type II Receptor Ligand on Bleomycin-Induced Pulmonary Fibrosis in Mice 96%
- Application of non-invasive low-intensity pulsed electric field with thermal cycling-hyperthermia for synergistically enhanced anticancer effect of chlorogenic acid on PANC-1 cells 96%
Similar papers in this journal
- Enhancement of Macrophage Function by the Antimicrobial Peptide Sublancin Protects Mice from Methicillin-Resistant Staphylococcus aureus 94%
- Schistosoma Japonicum infection in Treg-specific USP21 knock-out mice 92%
- Ion transport modulators differentially modulate inflammatory responses in THP-1 derived macrophages 92%
Similar papers in this journal
- Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic scoping review 95%
- Core Outcome Set for Clinical Trials of COVID-19 based on Traditional Chinese and Western Medicine 94%
- The mitochondrial deubiquitinase USP30 regulates AKT/mTOR signaling 94%
Similar papers in this journal
Similar papers in this journal
- JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation 93%
- Pro-cognitive Effects of Dual Tacrine Derivatives Acting as Cholinesterase Inhibitors and NMDA Receptor Antagonists 92%
- Molecular classification reveals the diverse genetic features and prognosis of gastric cancer: a multi-omics consensus ensemble clustering 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.